Toronto-Dominion Bank »

Kiniksa Pharmaceuticals shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2023-09-30 $69 4 17.25
2023-06-30 $0 4 0.00

More positions owned by Toronto-Dominion Bank

Charles Schwab Corporation (SCHW)
Invesco QQQ Trust Series 1 Etf (QQQ)
Rbc Cad (RY)
Apple (AAPL)
Microsoft Corporation (MSFT)
SPDR S&P 500 ETF Trust Etf (SPY)
iShares Russell 2000 ETF Etf (IWM)
Bank Of Montreal Cadcom (BMO)
Cibc Cad (CM)
Bk Nova Cad (BNS)
Tc Energy Corp (TRP)
Tor Dom Bk Cad (TD)
SPDR Gold Shares Etf (GLD)
NVIDIA Corporation (NVDA)
Canadian Natural Resources (CNQ)

View all positions for Toronto-Dominion Bank

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals